NESACS and the Advancement of Chemistry. The NESACS is a very active local section of the ACS with members involved in a numerous aspects of chemistry from academic to pharmaceutical to biotech and everything in between. With the large number of pharma and biotech companies in the Northeast, there is a strong section interest in science related to these sectors. Thursday, October 9, 2014. Biogen Idec, Cambridge, MA.

We invest in both privately held and publicly traded life science companies through a variety of investment approaches. 2 billion across three funds and demonstrated an ability to source, manage and exit attractive investments across multi.

Living with Sickle Cell Disease. Sign up for Email updates. We are dedicated to advancing new therapies to improve the lives of people living with sickle cell disease and other hemoglobinopathies. More than 160,000 individuals are living with sickle cell disease in the United States and Europe, and many more in Africa and Asia. Imara Lauds Signing of 21st Century Cures Act. Trying to Get Ahead of Sickle Cell Disease.

Tumor suppressor p53 trimer and DNA fragment. Before a malignant tumor is developed, the immune system tries to fight against proteins that are altered during their formation, producing certain cancer antibodies. A biosensor developed by scientists from the Complutense University of Madrid. To verify their effectiveness, the researchers applied the developed biosensor to the analysis of serum samples from four patients with colorec.